Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypogammaglobulinaemia requiring replacement intravenous immunoglobulin

Br J Haematol. 2009 Jun;146(1):120-2. doi: 10.1111/j.1365-2141.2009.07715.x. Epub 2009 May 9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Agammaglobulinemia / etiology*
  • Agammaglobulinemia / therapy
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Murine-Derived
  • Child
  • Humans
  • Immunoglobulins, Intravenous
  • Immunologic Factors / adverse effects*
  • Male
  • Rituximab
  • Thrombocytopenia / drug therapy*
  • Thrombocytopenia / immunology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunoglobulins, Intravenous
  • Immunologic Factors
  • Rituximab